Finance

Beta
Ask
Lists
NRXBF:OTCMKTS
Nurexone Biologic Inc
$0.39
+3.22%
(+0.012) 1D
Jun 16, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRXBF...
Open
$0.39
High
$0.39
Low
$0.39
Mkt. cap
50.63M
Avg. vol.
4.90K
Volume
240.00
52-wk high
$0.80
52-wk low
$0.37
Shares outstanding
73.40M
No. of employees
9
Open
$0.39
High
$0.39
Low
$0.39
Mkt. cap
50.63M
Avg. vol.
4.90K
Volume
240.00
52-wk high
$0.80
52-wk low
$0.37
Shares outstanding
73.40M
No. of employees
9
News stories
From sources across the web
About Nurexone Biologic Inc
CEO-
Employees9
Founded2011
Headquarters-
SectorBiotechnology
Websitenurexone.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
697.00K
703.00K
619.00K
630.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12M
763.00K
716.00K
1.13M
Operating expense
1.82M
1.47M
1.34M
1.76M
Total operating expenses
1.82M
1.47M
1.34M
1.76M
Operating income
-1.82M
-1.47M
-1.34M
-1.76M
Other non operating income
-
-20.00K
5.00K
6.00K
EBT including unusual items
-1.85M
-1.46M
-1.40M
-1.77M
EBT excluding unusual items
-1.85M
-1.46M
-1.40M
-1.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.85M
-1.46M
-1.40M
-1.77M
Net profit margin
-
-
-
-
Earnings per share
-0.02
-0.02
-0.02
-0.02
Interest and investment income
9.00K
21.00K
27.00K
-
Interest expense
-33.00K
-
-43.00K
-15.00K
Net interest expenses
-24.00K
21.00K
-16.00K
-15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.78M
-1.42M
-1.31M
-1.70M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer